anuPath
USP: The technology makes it simple to do some of the important test related to diabetes and Chronic Kidney Disease. The test are done with simply collecting the blood/urine and putting it onto the strips removing all intermediate steps. Also the technology makes these test very quick 1 min for each test
- Innovator's Name
- Product/Technology Description
PathShodh Healthcare Private Limited
Company has already established a pilot line to prove the manufacturability of the product. After successfully identifying the required infrastructure the company will follow a copy-paste approach to scale up the manufacturing. Also the required manpower is now highly trained to solve any issues faced during manufacturing. Company requires more investment in automation now to shorten the time to manufacture. In terms of marketing, already a customer base has been established and representation at major events attended by doctors have given a validation that technology will be acceptable by the market.
- Product Name: anuPath
- Description: PathShodh has developed novel point-of-care medical device for diabetes management and early detection of complications. The bi-markers measured are Glycated Hemoglobin, Glycated Albumin, Human serum Albumin, Microalbuminuria and Urine ACR. The technology is based on dry test strip and not on any enzymatic or immuno-assay based technology thus making it very robust to changes in temperature and humidity.
- Unique Selling Point: The technology makes it simple to do some of the important test related to diabetes and Chronic Kidney Disease. The test are done with simply collecting the blood/urine and putting it onto the strips removing all intermediate steps. Also the technology makes these test very quick 1 min for each test
